FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074466655> ?p ?o ?g. }

• W2074466655 endingPage "279" @default.
• W2074466655 startingPage "274" @default.
• W2074466655 abstract "The Journal of Clinical Pharmacology and New DrugsVolume 12, Issue 7 p. 274-279 Amantadine-HCl in the Treatment of Parkinson's Disease: A Controlled Trial D. J. MacFADYEN M.Sc., M.D., F.R.C.P.(C), D. J. MacFADYEN M.Sc., M.D., F.R.C.P.(C) Division of Neurology, Department of Medicine, Faculty of Medicine, University of British Columbia and the Vancouver General Hospital, and the Kinsmen Laboratory of Neurological Research, Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, B.C., Canada.Search for more papers by this authorT. W. PICTON M.Sc., M.D., T. W. PICTON M.Sc., M.D. Division of Neurology, Department of Medicine, Faculty of Medicine, University of British Columbia and the Vancouver General Hospital, and the Kinsmen Laboratory of Neurological Research, Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, B.C., Canada.Search for more papers by this authorL. ZELDOWICZ M.D. C.R.C.P.(C), L. ZELDOWICZ M.D. C.R.C.P.(C) Division of Neurology, Department of Medicine, Faculty of Medicine, University of British Columbia and the Vancouver General Hospital, and the Kinsmen Laboratory of Neurological Research, Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, B.C., Canada.Search for more papers by this authorP. L. McGEER M.D., Ph.D., P. L. McGEER M.D., Ph.D. Division of Neurology, Department of Medicine, Faculty of Medicine, University of British Columbia and the Vancouver General Hospital, and the Kinsmen Laboratory of Neurological Research, Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, B.C., Canada.Search for more papers by this author D. J. MacFADYEN M.Sc., M.D., F.R.C.P.(C), D. J. MacFADYEN M.Sc., M.D., F.R.C.P.(C) Division of Neurology, Department of Medicine, Faculty of Medicine, University of British Columbia and the Vancouver General Hospital, and the Kinsmen Laboratory of Neurological Research, Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, B.C., Canada.Search for more papers by this authorT. W. PICTON M.Sc., M.D., T. W. PICTON M.Sc., M.D. Division of Neurology, Department of Medicine, Faculty of Medicine, University of British Columbia and the Vancouver General Hospital, and the Kinsmen Laboratory of Neurological Research, Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, B.C., Canada.Search for more papers by this authorL. ZELDOWICZ M.D. C.R.C.P.(C), L. ZELDOWICZ M.D. C.R.C.P.(C) Division of Neurology, Department of Medicine, Faculty of Medicine, University of British Columbia and the Vancouver General Hospital, and the Kinsmen Laboratory of Neurological Research, Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, B.C., Canada.Search for more papers by this authorP. L. McGEER M.D., Ph.D., P. L. McGEER M.D., Ph.D. Division of Neurology, Department of Medicine, Faculty of Medicine, University of British Columbia and the Vancouver General Hospital, and the Kinsmen Laboratory of Neurological Research, Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, B.C., Canada.Search for more papers by this author First published: July 1972 https://doi.org/10.1002/j.1552-4604.1972.tb00055.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Schwab, R. S., England, A. C., Poskanzer, D. C., and Young, R. R.: Amantadine in the treatment of Parkinson's disease. J.A.M.A. 208: 1168 (1969). 2 Jargensen, P. B., Bergin, J. D., Haas, L., Cuningham, J. A. K., Morah, D. D., Pollock, M., Robinson, R. G., and Spears, G. F. S.: Controlled trial of amantadine hydrochloride in Parkinson's disease. New Zealand Med. J. 73: 263 (1971). 3 Parkes, J. D., Calver, D. M., Zilkha, K. J., and Knill-Jones, R. P.: Controlled trial of amantadine HCl in Parkinson's disease. Lancet 1: 259 (1970). 4 Fieschi, C., Nardini, M., Casacchia, M., and Tedone, M. E.: Amantadine for Parkinson's disease. Lancet 1: 945 (1970). 5 Millac, P., Hansen, I., Espir, M. I. E., and Slyfield, D. C.: Treatment of parkinsonism with L-Dopa and amantadine. Lancet 1: 464 (1970). 6 Hunter, K. R., Stern, G. M., Laurence, D. R., and Armitage, P.: Amantadine in parkinsonism. Lancet 1: 1127 (1970). 7 Schwab, R. S.: Combining L-Dopa and Amantadine Hydrochloride (Symmetrel). In A. Barbeau, and F. H. McDowell, editors: L-Dopa and Parkinsonism. Philadelphia, F. A. Davis, 1970. 8 Scotti, G.: Combined Treatment of Parkinson's disease with amantadine and L-dopa. Lancet 1: 1394 (1970). 9 Godwin-Austen, R. B., Frears, C. C., Bergmann, S., Parkes, J. D., and Knill-Jones, R. P.: Combined treatment of parkinsonism with L-dopa and amantadine. Lancet 2: 383 (1970). 10 Voller, G. W.: Treatment of Parkinson's disease with amantadine. Deutsch. Med. Wschr. 95: 934 (1970). 11 Parkes, J. D., Zilkha, K. J., Marsden, P., Baxter, R. C. H., and Knill-Jones, R. P.: Amantadine dosage in treatment of Parkinson's disease. Lancet 1: 1130 (1970). 12 Shealy, C. N., Weeth, J. B., and Mercier, D.: Livido reticularis in patients with parkinsonism receiving amantadine. J.A.M.A. 212: 1522 (1970). 13 Grelak, R. P., Clark, R., Stump, J. M., and Vernier, V. G.: Amantadine-dopamine interaction: possible mode of action in parkinsonism. Science 169: 203 (1970). 14 Fibiger, H. C., Fox, M., McGeer, E. G., and McGeer, P. L.: The effect of amantadine on spontaneous locomotor activity in the rat. J. Pharm. Pharmac. 23: 724 (1971). 15 Merrick, E. M.: The Use of Amantadine HCl in the Treatment of Drug-Induced Parkinsonism. Seminar on Amantadine HCl in Parkinson's Disease, Wilmington, Delaware, January 1971. Citing Literature Volume12, Issue7July 1972Pages 274-279 ReferencesRelatedInformation" @default.
• W2074466655 created "2016-06-24" @default.
• W2074466655 creator A5007669956 @default.
• W2074466655 creator A5057901720 @default.
• W2074466655 creator A5077471876 @default.
• W2074466655 creator A5084074379 @default.
• W2074466655 date "1972-07-01" @default.
• W2074466655 modified "2023-09-30" @default.
• W2074466655 title "Amantadine‐HCl in the Treatment of Parkinson's Disease: A Controlled Trial" @default.
• W2074466655 cites W1992601548 @default.
• W2074466655 cites W1998369503 @default.
• W2074466655 cites W2027451203 @default.
• W2074466655 cites W2035912870 @default.
• W2074466655 cites W2050902401 @default.
• W2074466655 cites W2051661215 @default.
• W2074466655 cites W2055680935 @default.
• W2074466655 cites W2066909315 @default.
• W2074466655 cites W2070041339 @default.
• W2074466655 cites W2073486423 @default.
• W2074466655 cites W2074181000 @default.
• W2074466655 cites W2140600662 @default.
• W2074466655 doi "https://doi.org/10.1002/j.1552-4604.1972.tb00055.x" @default.
• W2074466655 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/4483534" @default.
• W2074466655 hasPublicationYear "1972" @default.
• W2074466655 type Work @default.
• W2074466655 sameAs 2074466655 @default.
• W2074466655 citedByCount "0" @default.
• W2074466655 crossrefType "journal-article" @default.
• W2074466655 hasAuthorship W2074466655A5007669956 @default.
• W2074466655 hasAuthorship W2074466655A5057901720 @default.
• W2074466655 hasAuthorship W2074466655A5077471876 @default.
• W2074466655 hasAuthorship W2074466655A5084074379 @default.
• W2074466655 hasConcept C118552586 @default.
• W2074466655 hasConcept C144024400 @default.
• W2074466655 hasConcept C16568411 @default.
• W2074466655 hasConcept C29595303 @default.
• W2074466655 hasConcept C2992019943 @default.
• W2074466655 hasConcept C3017595490 @default.
• W2074466655 hasConcept C3018669867 @default.
• W2074466655 hasConcept C512399662 @default.
• W2074466655 hasConcept C71924100 @default.
• W2074466655 hasConceptScore W2074466655C118552586 @default.
• W2074466655 hasConceptScore W2074466655C144024400 @default.
• W2074466655 hasConceptScore W2074466655C16568411 @default.
• W2074466655 hasConceptScore W2074466655C29595303 @default.
• W2074466655 hasConceptScore W2074466655C2992019943 @default.
• W2074466655 hasConceptScore W2074466655C3017595490 @default.
• W2074466655 hasConceptScore W2074466655C3018669867 @default.
• W2074466655 hasConceptScore W2074466655C512399662 @default.
• W2074466655 hasConceptScore W2074466655C71924100 @default.
• W2074466655 hasIssue "7" @default.
• W2074466655 hasLocation W20744666551 @default.
• W2074466655 hasLocation W20744666552 @default.
• W2074466655 hasOpenAccess W2074466655 @default.
• W2074466655 hasPrimaryLocation W20744666551 @default.
• W2074466655 hasRelatedWork W2003559630 @default.
• W2074466655 hasRelatedWork W2046565830 @default.
• W2074466655 hasRelatedWork W2053565155 @default.
• W2074466655 hasRelatedWork W2098519255 @default.
• W2074466655 hasRelatedWork W2106188661 @default.
• W2074466655 hasRelatedWork W2522386141 @default.
• W2074466655 hasRelatedWork W2604816603 @default.
• W2074466655 hasRelatedWork W4211178222 @default.
• W2074466655 hasRelatedWork W4288046443 @default.
• W2074466655 hasRelatedWork W4293180912 @default.
• W2074466655 hasVolume "12" @default.
• W2074466655 isParatext "false" @default.
• W2074466655 isRetracted "false" @default.
• W2074466655 magId "2074466655" @default.
• W2074466655 workType "article" @default.